Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 70 | 0 |
| Gross Profit | N/A | N/A | N/A | 70 | N/A |
| Operating Expenses | 97 | 167 | 77 | 56 | 6,322 |
| Operating Income | -97 | -167 | -77 | 15 | -6,322 |
| Interest Expense | 216 | 235 | 208 | 185 | 257 |
| Other Income | 34 | -73 | -507 | 212 | -271 |
| Pre-tax Income | -278 | -475 | -791 | 41 | -6,850 |
| Net Income Continuous | -278 | -475 | -791 | 41 | -6,850 |
| Minority Interests | -68 | -67 | -55 | -74 | -93 |
| Net Income | $-210 | $-409 | $-736 | $115 | $-6,757 |
| EPS Basic Total Ops | 0.00 | 0.00 | N/A | 0.00 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| EPS Diluted Total Ops | 0.00 | 0.00 | N/A | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| EBITDA(a) | $-32 | $-129 | $225 | $-237 | $-153 |